Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jan. 28, 2012	Jan. 29, 2011	Jan. 30, 2010
Operating activities:
Net income	$ 207,064	$ 222,524	$ 200,369
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	82,851	74,041	71,501
Deferred income taxes	10,456	20,485	18,014
KB Toys matters	0	0	409
Non-cash share-based compensation expense	24,993	24,628	20,275
Excess tax benefit from share-based awards	(2,701)	(13,779)	(1,568)
Non-cash impairment charge	2,242	18	358
Loss on disposition of equipment	1,376	639	1,072
Gain on sale of real estate	0	0	(12,964)
Pension expense, net of contributions	2,023	4,479	(5,193)
Change in assets and liabilities, excluding effects of acquisition:
Inventories	(54,512)	(30,809)	5,279
Accounts payable	31,555	(7,045)	73,889
Current income taxes	10,293	12,043	(2,791)
Other current assets	(6,082)	(5,250)	(2,177)
Other current liabilities	(16,465)	(5,816)	18,064
Other assets	(4,098)	(2,988)	(5,285)
Other liabilities	29,476	22,087	12,774
Net cash provided by operating activities	318,471	315,257	392,026
Investing activities:
Capital expenditures	(131,293)	(107,563)	(78,708)
Cash proceeds from sale of property and equipment	867	1,301	861
Purchase of business, net of cash acquired	1,835	0	0
Return from (Deposit in) restricted account	8,000	(8,000)	0
Other	(121)	(290)	(90)
Net cash used in investing activities	(120,712)	(114,552)	(77,937)
Financing activities:
Net proceeds from borrowings under bank credit facility	65,900	0	(61,700)
Payment of notes payable	(16,664)	0	0
Payment of capital lease obligations	(1,953)	(2,463)	(2,612)
Proceeds from the exercise of stock options	10,409	32,512	4,931
Excess tax benefit from share-based awards	2,701	13,779	1,568
Payment for treasury shares acquired	(363,957)	(350,823)	(1,849)
Deferred bank credit facility fees paid	(2,970)	0	(5,579)
Other	279	96	112
Net cash used in financing activities	(306,255)	(306,899)	(65,129)
Impact of foreign currency on cash	(496)	0	0
(Decrease) Increase in cash and cash equivalents	(108,992)	(106,194)	248,960
Cash and cash equivalents:
Beginning of period	177,539	283,733	34,773
End of period	$ 68,547	$ 177,539	$ 283,733